Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
"Lysosomal glycogen storage disease with normal acid maltase" which was originally described by Danon et al., is characterized clinically by cardiomyopathy, myopathy and variable mental retardation. The pathological hallmark of the disease is intracytoplasmic vacuoles containing autophagic material and glycogen in skeletal and cardiac muscle cells. Sarcolemmal proteins and basal lamina are associated with the vacuolar membranes. Here we report ten unrelated patients, including one of the patients from the original case report, who have primary deficiencies of LAMP-2, a principal lysosomal membrane protein. From these results and the finding that LAMP-2-deficient mice manifest a similar vacuolar cardioskeletal myopathy, we conclude that primary LAMP-2 deficiency is the cause of Danon disease. To our knowledge this is the first example of human cardiopathy-myopathy that is caused by mutations in a lysosomal structural protein rather than an enzymatic protein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“| Cardiomyopathies | Whole‐body deletion of Lamp2 | Accelerated development of a vacuolar cardioskeletal myopathy similar to Danon disease | Nishino et al (2000), Tanaka et al (2000) |”
From Autophagy in major human diseases (2021) · cites this paper as Nishino et al (2000)
In the citing paper
“In addition, broad‐spectrum autophagic defects tied to the systemic ablation of LAMP2 (causing Danon disease) account for the early development of hypertrophic cardiomyopathy (Nishino et al, 2000; Tanaka et al, 2000).”
From Autophagy in major human diseases (2021) · cites this paper as Nishino et al, 2000
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
An association between migraine and cutaneous allodynia
Burstein, R., Yarnitsky, D., Goor‐Aryeh, I., Ransil, B. J., & Bajwa, Z. H. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200005)47:5<684::aid-ana27>3.0.co;2-o · Cited by 1,025
Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice
Tanaka, Y., Guhde, G., Suter, A., Eskelinen, E.-L., Hartmann, D., Lüllmann-Rauch, R., Janssen, P. M. L., Blanz, J., von Figura, K., & Saftig, P. (2000) · Nature · doi:10.1038/35022595 · Cited by 925 · cited 1×
“From these results and the finding that LAMP-2-deficient mice manifest a similar vacuolar cardioskeletal myopathy, we conclude that primary LAMP-2 deficiency is the cause of Danon diseas”
ResultA novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis
Town, M., Jean, G., Cherqui, S., Attard, M., Forestier, L., Whitmore, S. A., Callen, D. F., Gribouval, O., Broyer, M., Bates, G. P., et al. (1998) · Nature Genetics · doi:10.1038/ng0498-319 · Cited by 639 · cited 1×
“Our results, together with the recent identification of mutations in the lysosomal proteins cystinosin and sialin that cause nephropathic cystinosi”
ResultLysosomal glycogen storage disease with normal acid maltase
Danon, M. J., Oh, S. J., DiMauro, S., Manaligod, J. R., Eastwood, A., Naidu, S., & Schliselfeld, L. H. (1981) · Neurology · doi:10.1212/wnl.31.1.51 · Cited by 405 · cited 4×
“In 1981, Danon et al.1 reported two boys with the clinical triad of cardiomyopathy, myopathy and mental retardation.”
BackgroundInfluentialSelf-citationSaitoh, O., Wang, W. C., Lotan, R., & Fukuda, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42823-2 · Cited by 308
A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases
Verheijen, F. W., Verbeek, E., Aula, N., Beerens, C. E. M. T., Havelaar, A. C., Joosse, M., Peltonen, L., Aula, P., Galjaard, H., van der Spek, P. J., et al. (1999) · Nature Genetics · doi:10.1038/70585 · Cited by 293
Lysosomes, a meeting point of proteins, chaperones, and proteases
Cuervo, A. M., & Dice, J. F. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050185 · Cited by 201 · cited 1×
“Alternatively, the unusual muscle pathology in DD might result from impaired lysosomal protein processing because the cytoplasmic tail of LAMP-2 functions as a receptor for the uptake of certain proteins into lysosome in association with the relative molecular mass ( M r ) 73,000 heat shock cognate protei”
BackgroundPattern of malformations in the axial skeleton in human triploid fetuses
Kjær, I., Keeling, J. W., Smith, N. M., & Hansen, B. F. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19971017)72:2<135::aid-ajmg3>3.0.co;2-u · Cited by 120
Konecki, D. S., Foetisch, K., Zimmer, K.-P., Schlotter, M., & Konecki, U. L. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2528 · Cited by 116 · cited 1×
“Human exon 9 exists in two forms, 9a and 9b, which are alternatively spliced and produce two isoforms, LAMP-2a and LAMP-2b, respectivel”
Background
Research works printed but not linked: 1
- Lewin, B. Genes VI (Oxford Univ. Press, Oxford, 1997).
Cited by
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Autophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418
“These results indicate that autophagy plays a cell-autonomous role in axonal homeostasis (Komatsu et al., 2007b; Nishiyama et al., 2007).”
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Autophagy as a Regulated Pathway of Cellular Degradation
Klionsky, D. J., & Emr, S. D. (2000) · Science · doi:10.1126/science.290.5497.1717 · Cited by 3,608
Loss of autophagy in the central nervous system causes neurodegeneration in mice
Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J.-I., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., et al. (2006) · Nature · doi:10.1038/nature04723 · Cited by 3,500
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897
2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
Biological Functions of Autophagy Genes: A Disease Perspective
Levine, B., & Kroemer, G. (2019) · Cell · doi:10.1016/j.cell.2018.09.048 · Cited by 2,832
Autophagy in Human Health and Disease
Choi, A. M. K., Ryter, S. W., & Levine, B. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1205406 · Cited by 2,583
Autophagy in Health and Disease: A Double-Edged Sword
Shintani, T., & Klionsky, D. J. (2004) · Science · doi:10.1126/science.1099993 · Cited by 2,534
Intracellular Functions of N-Linked Glycans
Helenius, A., & Aebi, A. M. (2001) · Science · doi:10.1126/science.291.5512.2364 · Cited by 2,405
Impairment of starvation-induced and constitutive autophagy in Atg7 -deficient mice
Komatsu, M., Waguri, S., Ueno, T., Iwata, J., Murata, S., Tanida, I., Ezaki, J., Mizushima, N., Ohsumi, Y., Uchiyama, Y., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200412022 · Cited by 2,331
“…J O U R N A L O F C E L L B IO L O G Y © The Rockefeller University Press $8.00 The Journal of Cell Biology, Vol. 169, No. 3, May 9, 2005 425–434 http://www.jcb.org/cgi/doi/10.1083/jcb.200412022 JCB: ARTICLE JCB 425 Impairment of starvation-induced and constitutive autophagy in Atg7 -deficient mice”
BackgroundInfluentialMizushima, N., Yamamoto, A., Matsui, M., Yoshimori, T., & Ohsumi, Y. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-09-0704 · Cited by 2,105
Self-citationRegulation of Mammalian Autophagy in Physiology and Pathophysiology
Ravikumar, B., Sarkar, S., Davies, J. E., Futter, M., Garcia-Arencibia, M., Green-Thompson, Z. W., Jimenez-Sanchez, M., Korolchuk, V. I., Lichtenberg, M., Luo, S., et al. (2010) · Physiological Reviews · doi:10.1152/physrev.00030.2009 · Cited by 1,727
Signals from the lysosome: a control centre for cellular clearance and energy metabolism
Settembre, C., Fraldi, A., Medina, D. L., & Ballabio, A. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3565 · Cited by 1,697
Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function
Saftig, P., & Klumperman, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2745 · Cited by 1,648
“cgi?id=300257">Danon disease , a rare disorder characterized by LAMP2 mutations that lead to a clinical triad of hypertrophic cardiomyopathy, skeletal myopathy and mental retardatio”
BackgroundAutophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress
Nakai, A., Yamaguchi, O., Takeda, T., Higuchi, Y., Hikoso, S., Taniike, M., Omiya, S., Mizote, I., Matsumura, Y., Asahi, M., et al. (2007) · Nature Medicine · doi:10.1038/nm1574 · Cited by 1,520
“Mice with a deficiency of lysosome-associated membrane protein-2, a model for Danon disease, show an accumulation of autophagic vacuoles and cardiomyopath”
BackgroundSynaptic Modification by Correlated Activity: Hebb's Postulate Revisited
Bi, G.-Q., & Poo, M.-M. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.139 · Cited by 1,489
LC3 conjugation system in mammalian autophagy
Tanida, I., Ueno, T., & Kominami, E. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.05.009 · Cited by 1,461
“Danon disease is an X-chromosome-linked myopathy and cardiomyopathy caused by mutations of the LAMP-2 gene (Nishino et al., 2000).”
BackgroundAutophagy, mitochondria and oxidative stress: cross-talk and redox signalling.
Lee, J., Giordano, S., & Zhang, J. (2012) · Biochemical Journal · doi:10.1042/bj20111451 · Cited by 1,438
Dissection of Autophagosome Formation Using Apg5-Deficient Mouse Embryonic Stem Cells
Mizushima, N., Yamamoto, A., Hatano, M., Kobayashi, Y., Kabeya, Y., Suzuki, K., Tokuhisa, T., Ohsumi, Y., & Yoshimori, T. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.4.657 · Cited by 1,361
“Defective autophagy may contribute to the pathogenesis of mammary tumors (Liang et al., 1999) and a specific type of myopathy (Nishino et al., 2000; Tanaka et al., 2000).”
BackgroundSelf-citationAutophagy at the crossroads of catabolism and anabolism
Kaur, J., & Debnath, J. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4024 · Cited by 991
Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy
Eskelinen, E.-L. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2006.08.005 · Cited by 955
Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice
Tanaka, Y., Guhde, G., Suter, A., Eskelinen, E.-L., Hartmann, D., Lüllmann-Rauch, R., Janssen, P. M. L., Blanz, J., von Figura, K., & Saftig, P. (2000) · Nature · doi:10.1038/35022595 · Cited by 925
“This theory is further substantiated by the finding that human LAMP-2 deficienc”
ResultMethods for monitoring autophagy
Mizushima, N. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.02.005 · Cited by 881
“…may be involved in a certain type of cell death (Clarke, 1990) and human diseases such as neurodegener- ative diseases (Petersen et al., 2001; Ravikumar, Duden, & Rubinsztein, 2002), 1-antitrypsin deficiency (Teckman & Perlmutter, 2000), myopathy (Nishino et al., 2000) and cancer (Qu et al., 2003).”
BackgroundAutophagosome Formation in Mammalian Cells.
Mizushima, N., Ohsumi, Y., & Yoshimori, T. (2002) · Cell Structure and Function · doi:10.1247/csf.27.421 · Cited by 877
Autophagy and mitophagy in cardiovascular disease
Bravo-San Pedro, J. M., Kroemer, G., & Galluzzi, L. (2017) · Circulation Research · doi:10.1161/circresaha.117.311082 · Cited by 843
“Along similar lines, Lamp2 mice—which exhibit defects in various forms of autophagy at the whole-body level—spontaneously developed a vacuolar myopathy affecting the cardiac and skeletal muscle that resembles Danon disease.(28) Moreover, mice engineered to overexpress miR-212 and miR-132—2 miRNAs that inhibit the proa…”
BackgroundPharmacological modulation of autophagy: therapeutic potential and persisting obstacles
Galluzzi, L., Bravo-San Pedro, J. M., Levine, B., Green, D. R., & Kroemer, G. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.22 · Cited by 842
The cell biology of lysosomal storage disorders
Futerman, A. H., & van Meer, G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1423 · Cited by 796
“Finally,mutations in the abundant lysosomal protein lysosome-associated membrane protein-2 (LAMP2) cause Danon disease 29 .”
Autophagy in the Cellular Energetic Balance
Singh, R., & Cuervo, A. M. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.04.004 · Cited by 788
“Recent studies have revealed that the primary defect is in the ability to deliver the material sequestered in autophagosomes, including glycogen, to lysosomes for degradation (Nishino et al., 2000).”
Lysosomes as a therapeutic target
Bonam, S. R., Wang, F., & Muller, S. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0036-1 · Cited by 759
“Further investigations are needed to support this assertion.”
BackgroundCD68/macrosialin: not just a histochemical marker
Chistiakov, D. A., Killingsworth, M. C., Myasoedova, V. A., Orekhov, A. N., & Bobryshev, Y. V. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2016.116 · Cited by 724
Autophagy: A lysosomal degradation pathway with a central role in health and disease
Eskelinen, E.-L., & Saftig, P. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.07.014 · Cited by 703
“Studies in LAMP-2 deficientmice revealed in part similar findings [85].”
BackgroundResultInfluentialAt the acidic edge: emerging functions for lysosomal membrane proteins
Eskelinen, E.-L., Tanaka, Y., & Saftig, P. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00005-9 · Cited by 660
Glycogen Storage Diseases Presenting as Hypertrophic Cardiomyopathy
Arad, M., Maron, B. J., Gorham, J. M., Johnson, W. H., Saul, J. P., Perez-Atayde, A. R., Spirito, P., Wright, G. B., Kanter, R. J., Seidman, C. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa033349 · Cited by 650
Metabolic control of cell death
Green, D. R., Galluzzi, L., & Kroemer, G. (2014) · Science · doi:10.1126/science.1250256 · Cited by 647
Pastores, G. M. (2012) · Swaiman's Pediatric Neurology · doi:10.1016/b978-1-4377-0435-8.00036-6 · Cited by 633
Maturation of Autophagic Vacuoles in Mammalian Cells
Eskelinen, E.-L. (2005) · Autophagy · doi:10.4161/auto.1.1.1270 · Cited by 626
Regulation and role of autophagy in mammalian cells
Meijer, A. J., & Codogno, P. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.02.002 · Cited by 615
“Autophagy and myopathies.Deficiency of the lysosomal protein LAMP-2 was shown to cause Danon disease, an X-linked vacuolar cardiomyopathy and myopathy (Nishino et al., 2000).”
BackgroundAutophagy in Human Health and Disease
(2013) · New England Journal of Medicine · doi:10.1056/nejmc1303158 · Cited by 615
Specialized roles for cysteine cathepsins in health and disease
Reiser, J., Adair, B., & Reinheckel, T. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42918 · Cited by 580
Chaperone-Assisted Selective Autophagy Is Essential for Muscle Maintenance
Arndt, V., Dick, N., Tawo, R., Dreiseidler, M., Wenzel, D., Hesse, M., Fürst, D. O., Saftig, P., Saint, R., Fleischmann, B. K., et al. (2010) · Current Biology · doi:10.1016/j.cub.2009.11.022 · Cited by 574
Machinery, regulation and pathophysiological implications of autophagosome maturation
Zhao, Y. G., Codogno, P., & Zhang, H. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00392-4 · Cited by 572
Myocytes Die by Multiple Mechanisms in Failing Human Hearts
Kostin, S., Pool, L., Elsässer, A., Hein, S., Drexler, H. C. A., Arnon, E., Hayakawa, Y., Zimmermann, R., Bauer, E., Klövekorn, W.-P., et al. (2003) · Circulation Research · doi:10.1161/01.res.0000067471.95890.5c · Cited by 564
The Role of Autophagy in the Heart
Sciarretta, S., Maejima, Y., Zablocki, D., & Sadoshima, J. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021317-121427 · Cited by 547
Essential Roles of Atg5 and FADD in Autophagic Cell Death
Pyo, J.-O., Jang, M.-H., Kwon, Y.-K., Lee, H.-J., Jun, J.-I., Woo, H.-N., Cho, D.-H., Choi, B., Lee, H., Kim, J.-H., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413934200 · Cited by 539
Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction
Tai, H.-C., & Schuman, E. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2499 · Cited by 532
“LAMP2 mutations are found in Danon disease, an LSD that results in myopathy, cardiomyopathy and mental retardatio”
BackgroundConsequences of the selective blockage of chaperone-mediated autophagy
Massey, A. C., Kaushik, S., Sovak, G., Kiffin, R., & Cuervo, A. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507436103 · Cited by 529
The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death
González-Polo, R.-A., Boya, P., Pauleau, A.-L., Jalil, A., Larochette, N., Souquère, S., Eskelinen, E.-L., Pierron, G., Saftig, P., & Kroemer, G. (2005) · Journal of Cell Science · doi:10.1242/jcs.02447 · Cited by 524
“Loss of LAMP2 is also at the etiology of Danon disease, an X-linked lysosomal glycogen storage disease affecting infants or adolescents with a clinical triad of cardiomyopathy, myopathy and mental retardation (Nishino et al., 2000).”
BackgroundAutophagy: Basic Principles and Relevance to Disease
Kundu, M., & Thompson, C. B. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.2.010506.091842 · Cited by 523
Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease
Ju, J.-S., Fuentealba, R. A., Miller, S. E., Jackson, E., Piwnica-Worms, D., Baloh, R. H., & Weihl, C. C. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200908115 · Cited by 494
Impaired Autophagosome Clearance Contributes to Cardiomyocyte Death in Ischemia/Reperfusion Injury
Ma, X., Liu, H., Foyil, S. R., Godar, R. J., Weinheimer, C. J., Hill, J. A., & Diwan, A. (2012) · Circulation · doi:10.1161/circulationaha.111.041814 · Cited by 491
“(7) Jadot M, Wattiaux R, Mainferme F, Dubois F, Claessens A, Wattiaux-De CS.”
Kubli, D. A., Zhang, X., Lee, Y., Hanna, R. A., Quinsay, M. N., Nguyen, C. K., Jimenez, R., Petrosyan, S., Murphy, A. N., & Gustafsson, Å. B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.411363 · Cited by 476
Autophagy: for better or for worse
Wirawan, E., Berghe, T. V., Lippens, S., Agostinis, P., & Vandenabeele, P. (2012) · Cell Research · doi:10.1038/cr.2011.152 · Cited by 465
Lipshultz, S. E., Law, Y. M., Asante-Korang, A., Austin, E. D., Dipchand, A. I., Everitt, M. D., Hsu, D. T., Lin, K. Y., Price, J. F., Wilkinson, J. D., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000682 · Cited by 416
Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy
Cao, D. J., Wang, Z. V., Battiprolu, P. K., Jiang, N., Morales, C. R., Kong, Y., Rothermel, B. A., Gillette, T. G., & Hill, J. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015081108 · Cited by 405
“LAMP-2 deficiency in these patients results in lysosomal dysfunction, accumulation of autophagic vacuoles, and consequent skeletal and cardiac myopathies (46).”
BackgroundAutophagy in lysosomal storage disorders
Lieberman, A. P., Puertollano, R., Raben, N., Slaugenhaupt, S., Walkley, S. U., & Ballabio, A. (2012) · Autophagy · doi:10.4161/auto.19469 · Cited by 399
“Danon disease was the first LSD in which an involvement of autophagy was reported.(52) Accumulation of autophagic vacuoles is detected in several tissues, particularly the muscle, from a mouse model of the disease.”
BackgroundRoles of Autophagy in Oxidative Stress
Yun, H. R., Jo, Y. H., Kim, J., Shin, Y., Kim, S. S., & Choi, T. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093289 · Cited by 396
Altered lipid content inhibits autophagic vesicular fusion
Koga, H., Kaushik, S., & Cuervo, A. M. (2010) · The FASEB Journal · doi:10.1096/fj.09-144519 · Cited by 395
Autophagy in Ischemic Heart Disease
Gustafsson, A. B., & Gottlieb, R. A. (2009) · Circulation Research · doi:10.1161/circresaha.108.187427 · Cited by 395
The role of autophagy in the heart
Nishida, K., Kyoi, S., Yamaguchi, O., Sadoshima, J., & Otsu, K. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.163 · Cited by 393
“level of autophagy is altered not only in response to stress such as ischemia/reperfusion(14,15) but also to stress triggered by cardiovascular diseases such as cardiac hypertrophy(16) and heart failure.(17,18) Heart failure is preceded by a process”
BackgroundAutophagy in Atherosclerosis: A Cell Survival and Death Phenomenon With Therapeutic Potential
Martinet, W., & De Meyer, G. R. Y. (2009) · Circulation Research · doi:10.1161/circresaha.108.188318 · Cited by 381
Autophagy: An Essential Degradation Program for Cellular Homeostasis and Life
Chun, Y., & Kim, J. (2018) · Cells · doi:10.3390/cells7120278 · Cited by 380
“For instance, accumulation of glycogen granules in the muscles of patients with Danon disease, which causes cardiomyopathy, proximal muscle weakness, and mental retardation [191], is demonstrated primarily by the defects in autophagy.”
BackgroundThe role of sirtuins in cardiac disease
Matsushima, S., & Sadoshima, J. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00053.2015 · Cited by 375
Autophagy: a barrier or an adaptive response to cancer
Ogier-Denis, E., & Codogno, P. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(03)00004-0 · Cited by 365
Role of lysosomes in physiological activities, diseases, and therapy
Zhang, Z., Yue, P., Lu, T., Wang, Y., Wei, Y., & Wei, X. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01087-1 · Cited by 356
“Defective CMA caused by mutated LAMP2 has been claimed in Danon disease [159].”
BackgroundTanida, I., Tanida-Miyake, E., Ueno, T., & Kominami, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000752200 · Cited by 344
Clinical Outcome and Phenotypic Expression in <emph type="ital">LAMP2</emph> Cardiomyopathy
Maron, B. J. (2009) · JAMA · doi:10.1001/jama.2009.371 · Cited by 343
“Of note, the patients presented here with LAMP2 cardiomyopathy demonstrated a clinical profile dominated by cardiac manifestations, largely without overt evidence of the multisystem and extracardiac abnormalities (eg, mental retardation, hepatic involvement, and overt skeletal myopathy) reported in other patients with…”
InfluentialTargeting autophagy in obesity: from pathophysiology to management
Zhang, Y., Sowers, J. R., & Ren, J. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0009-1 · Cited by 338
Endocytosis and signaling: Cell logistics shape the eukaryotic cell plan
Sigismund, S., Confalonieri, S., Ciliberto, A., Polo, S., Scita, G., & Di Fiore, P. P. (2012) · Physiological Reviews · doi:10.1152/physrev.00005.2011 · Cited by 338
Autophagy in cardiovascular biology
Lavandero, S., Chiong, M., Rothermel, B. A., & Hill, J. A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci73943 · Cited by 331
“Glycogen storage disease can present as hypertrophic cardiomyopathy (73, 79, 80).”
Role of LAMP-2 in Lysosome Biogenesis and Autophagy
Eskelinen, E.-L., Illert, A. L., Tanaka, Y., Schwarzmann, G., Blanz, J., von Figura, K., & Saftig, P. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0114 · Cited by 323
Crosstalk Between Autophagy and Apoptosis in Heart Disease
Nishida, K., Yamaguchi, O., & Otsu, K. (2008) · Circulation Research · doi:10.1161/circresaha.108.175448 · Cited by 316
Huang, J., & Klionsky, D. J. (2007) · Cell Cycle · doi:10.4161/cc.6.15.4511 · Cited by 315
Khandia, R., Dadar, M., Munjal, A., Dhama, K., Karthik, K., Tiwari, R., Yatoo, M. I., Iqbal, H. M. N., Singh, K. P., Joshi, S. K., et al. (2019) · Cells · doi:10.3390/cells8070674 · Cited by 314
“Similarly, LAMP-2-deficient mice displayed increased autophagic vacuole accumulation and could not degrade proteins, thereby promoting cardiomyopathy [371,372].”
BackgroundGenetic basis of limb-girdle muscular dystrophies: the 2014 update.
Nigro, V., & Savarese, M. (2014) · PubMed Central · Cited by 310
Lamp-2a Facilitates MHC Class II Presentation of Cytoplasmic Antigens
Zhou, D., Li, P., Lin, Y., Lott, J. M., Hislop, A. D., Canaday, D. H., Brutkiewicz, R. R., & Blum, J. S. (2005) · Immunity · doi:10.1016/j.immuni.2005.03.009 · Cited by 309
Why should autophagic flux be assessed?
Zhang, X.-J., Chen, S., Huang, K.-X., & Le, W.-D. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.184 · Cited by 307
Autophagy and human disease: emerging themes
Schneider, J. L., & Cuervo, A. M. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2014.04.003 · Cited by 303
“Defective autophagosome clearance can also be due to primary defects in the proteins that participate in autophagosome–lysosome fusion such as mitofusin 2, whose depletion in cardiomyocytes renders them susceptible to ischemia–reperfusion [29], UVRAG, mutated in human gastric cancer [30], EPG5, implicated in the syste…”
Lysosomal Biology and Function: Modern View of Cellular Debris Bin
Trivedi, P. C., Bartlett, J. J., & Pulinilkunnil, T. (2020) · Cells · doi:10.3390/cells9051131 · Cited by 296
Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles
Bonora, M., Wieckowski, M. R., Sinclair, D. A., Kroemer, G., Pinton, P., & Galluzzi, L. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0074-0 · Cited by 294
Recessive mutations in EPG5 cause Vici syndrome, a multisystem disorder with defective autophagy
Cullup, T., Kho, A. L., Dionisi-Vici, C., Brandmeier, B., Smith, F., Urry, Z., Simpson, M. A., Yau, S., Bertini, E., McClelland, V., et al. (2013) · Nature Genetics · doi:10.1038/ng.2497 · Cited by 282
“…clinical level, skeletal and cardiac muscles involvement also feature prominently in other conditions with primary disturbance of autophagy such as X-linked recessive Danon disease [OMIM 300257], caused by failure of correct autolysosome formation due to mutations in the lysosomal LAMP-2 gene 37 .”
Traffic Jam: A Compendium of Human Diseases that Affect Intracellular Transport Processes
Aridor, M., & Hannan, L. A. (2000) · Traffic · doi:10.1034/j.1600-0854.2000.011104.x · Cited by 278
Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours
Miracco, C., Cosci, E., Oliveri, G., Luzi, P., Pacenti, L., Monciatti, I., Mannucci, S., Nisi, M. C. D., Toscano, M., Malagnino, V., et al. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.2.429 · Cited by 271
Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure
Thomas, R. L., Roberts, D. J., Kubli, D. A., Lee, Y., Quinsay, M. N., Owens, J. B., Fischer, K. M., Sussman, M. A., Miyamoto, S., & Gustafsson, Å. B. (2013) · Genes & Development · doi:10.1101/gad.215871.113 · Cited by 269
“In addition, Danon disease, caused by LAMP-2 deficiency, disrupts fusion between autophagosomes and lysosomes and leads to a lethal cardiomyopathy (Nishino et al. 2000).”
BackgroundAutophagy During Cardiac Stress: Joys and Frustrations of Autophagy
Gottlieb, R. A., & Mentzer, R. M. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135757 · Cited by 267
“Danon cardiomyopathy, a genetic disease arising from mutation of lysosome-associated membrane protein 2 (LAMP2), is characterized by a failure of autophagosomes to fuse with lysosomes (19).”
BackgroundEskelinen, E.-L., Schmidt, C. K., Neu, S., Willenborg, M., Fuertes, G., Salvador, N., Tanaka, Y., Lüllmann-Rauch, R., Hartmann, D., Heeren, J., et al. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-02-0103 · Cited by 265
Therapeutic Targeting of Autophagy in Disease: Biology and Pharmacology
Cheng, Y., Ren, X., Hait, W. N., & Yang, J.-M. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007120 · Cited by 262
“Mice with deficiency of LAMP2 show excessive accumulation of autophagic vacuoles and impaired autophagic degradation of long-lived proteins, which may contribute to the incidence of cardiomyopathy (Nishino et al., 2000; Tanaka et al., 2000).”
BackgroundChaperone-mediated autophagy: selectivity pays off
Cuervo, A. M. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.10.003 · Cited by 260
“Lastly, CMA is also likely to be altered in Danon’s disease, a type of vacuolar myopathy resulting from mutations in the LAMP2 gene [52].”
BackgroundLysosomal Membrane Proteins and Their Central Role in Physiology
Schwake, M., Schröder, B., & Saftig, P. (2013) · Traffic · doi:10.1111/tra.12056 · Cited by 258
“An example for such a disease are null mutations in the human LAMP-2 gene leading to Danon Disease (18), a disorder characterized by serious”
BackgroundInfluentialAutophagy in neurons: a review.
Larsen, K. E., & Sulzer, D. L. (2002) · PubMed · doi:10.14670/hh-17.897 · Cited by 241
Lysosomal proteolysis in skeletal muscle
Bechet, D., Tassa, A., Taillandier, D., Combaret, L., & Attaix, D. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.02.029 · Cited by 240
“The physiological importance of LAMP2 was supported by the finding that LAMP2 deficiency is the primary defect in human Danon disease ( Nishino et al., 2000), the clinical characteristics of which is myopathy and cardiomyopathy with massive accumulation of aut c trate p L tant b H s to t term”
BackgroundInfluentialAutophagy in Cardiovascular Aging
Abdellatif, M., Sedej, S., Carmona-Gutierrez, D., Madeo, F., & Kroemer, G. (2018) · Circulation Research · doi:10.1161/circresaha.118.312208 · Cited by 239
“Interestingly, a similar mutation in humans is associated with Danon disease, a lysosomal and glycogen storage disorder associated with cardiomyopathy.(168,169) Despite the fact that cardiac autophagy abrogation is not lethal, it may result in early-life detrimental effects, including defective cardiac morphogenesis.”
BackgroundClinicopathological features of genetically confirmed Danon disease
Sugie, K., Yamamoto, A., Murayama, K., Oh, S. J., Takahashi, M., Mora, M., Riggs, J. E., Colomer, J., Iturriaga, C., Meloni, A., et al. (2002) · Neurology · doi:10.1212/wnl.58.12.1773 · Cited by 237
“We sequenced the entire coding region, including both exons 9a and 9b, and the exon/intron junctions of the LAMP-2 gene as described.(2) Muscle biopsy.”
BackgroundMethodSelf-citationNatural history of Danon disease
Boucek, D., Jirikowic, J., & Taylor, M. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e31820ad795 · Cited by 233
The rapidly evolving view of lysosomal storage diseases
Parenti, G., Medina, D. L., & Ballabio, A. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202012836 · Cited by 230
“…storage disease) (Gahl et al, 1982; Verheijen et al, 1999) and other lysosomal membrane proteins (Danon disease, due to LAMP2 defective function) (Nishino et al, 2000; Tanaka et al, 2000), or are the consequence of defects in assembly and stability of multienzymatic complexes (galactosialidosis,…”
BackgroundDNA DEGRADATION IN DEVELOPMENT AND PROGRAMMED CELL DEATH
Nagata, S. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115811 · Cited by 230
Human NK cell lytic granules and regulation of their exocytosis
Krzewski, K., & Coligan, J. E. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00335 · Cited by 229
Metadata
- Authors
- Nishino, I., Fu, J., Tanji, K., Yamada, T., Shimojo, S., Koori, T., Mora, M., Riggs, J. E., Oh, S. J., Koga, Y., Sue, C. M., Yamamoto, A., Murakami, N., Shanske, S., Byrne, E., Bonilla, E., Nonaka, I., DiMauro, S., & Hirano, M.
- Affiliations
- Columbia University (US)
- Kyushu University (JP)
- St. Marianna University School of Medicine (JP)
- Yokohama Rosai Hospital (JP)
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- West Virginia University (US)
- University of Alabama at Birmingham (US)
- Kurume University (JP)
- National Center of Neurology and Psychiatry (JP)
- St Vincent's Hospital Melbourne (AU)
- Corresponding author
- Nishino, Ichizo
- ORCID
- Venue
- Nature
- Published
- 2000-08
- Volume
- 406
- Issue
- 6798
- Pages
- 906-910
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2109716633
- Cited by
- 959
- References
- 28
- Citations by year
- 2026: 24 · 2025: 31 · 2024: 30 · 2023: 44 · 2022: 35 · 2021: 44 · 2020: 45 · 2019: 46 · 2018: 57 · 2017: 45 · 2016: 62 · 2015: 44 · 2014: 40 · 2013: 51 · 2012: 45
- FWCI
- 14.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- Danon disease, lysosomal membrane proteins, lysosomal storage disease, cardiomyopathy, myopathy, intracytoplasmic vacuoles, glycogen storage disease
- MeSH terms
- DNA Mutational Analysis, Female, Humans, Immunohistochemistry, Genetic Linkage, Male, Membrane Glycoproteins, Molecular Sequence Data, Muscular Diseases, Cardiomyopathies, Vacuoles, X Chromosome, Blotting, Western, Antigens, CD, Lysosomal Storage Diseases, Sequence Analysis, DNA, Muscle, Skeletal, Lysosomal Membrane Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.